| |
Advanced Life Sciences Previews 2010 Milestones
Tue 5:00 pm ET (PR Newswire)
Advanced Life Sciences Holdings, Inc. , a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, is providing a preview of its priorities and anticipated milestones for 2010 based on a foundation of progress and strengthened strategic focus achieved in 2009.
|
|
Top-Ranked Analysts
|
Provided by StarMine
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 231B | | Price
/ Earnings: | NM | | Price
/ Book: | 8.8 | | Net
Profit Margin (mrq): | 0.3% | | Price
To Free Cash Flow (mrq): | -205.3 | | Return
on Equity: | 0.3% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 2.8% |
|